Impact of Blood Transfusions After Kidney Transplantation on Clinical Outcomes and Broadness of Sensitisation
Identification
- Public canonical key
- radar:r-409df374cedd1404e7c76c654c2a81ce
- Authors
- Stella L. Gerber · Matthias Diebold · Gideon Hönger · Caroline Wehmeier · Thomas E. Wolff · Edin Mujagić · Corinne C. Widmer · Andreas S. Buser · Stefan Schaub
- Reported year
- 2026
- Reported language
- en
- Source type
- article
- First detected
- 2026-11-14T02:12:53.847810+00:00
- Last metadata observation
- 2026-11-14T02:12:53.847810+00:00
- Last HTTP verification
- Not checked
Institutions reported by the source
University Hospital of Basel · Swiss Red Cross
Reported affiliation countries
CH
Documentary abstract — original language
Whether erythrocyte transfusion (ET) after kidney transplantation triggers formation of de novo donor-specific HLA-antibodies (HLA-DSA) and rejection remains debated. If this were true, ET should broaden HLA sensitisation, reflected by increased calculated panel reactive antibodies (cPRA) and de novo HLA-antibody specificities beyond HLA-DSA. This has not been investigated in detail yet. In this retrospective study we included 519 kidney transplant recipients having single antigen bead analyses pretransplant and at one-year posttransplant. ET was assessed both as a binary variable (with/without ET) and in quantity-based groups (without ET, 1-2 ET, 3-5 ET, > 5 ET). No significant differences were found between patients with/without ET in the one-year incidence of clinical rejection (19.7% vs. 15.3%, p = 0.43), clinical/subclinical rejection (30.0% vs. 28.6%, p = 0.86), TCMR (15.6% vs. 19.4%; p = 0.30) and AMR (15.6% vs. 10.1%; p = 0.19). Quantity-based analysis also showed no significant differences, except for higher AMR incidence in patients receiving > 5 ET (p = 0.03). This association lost significance after multivariable adjustment in a time-dependent Cox model (HR: 0.91 [95%-CI: 0.52-1.59]; p = 0.74). De novo HLA-DSA incidence was similar in patients with/without ET (3.5% vs. 3.1%, p = 0.80) and across quantity-based groups (p = 0.17). cPRA change did not differ between patients with/without ET or across quantity-based groups. No preferential sensitisation against highly prevalent HLA-antigens Class I was observed (e.g., HLA-A1 [0.4%], HLA-A2 [0.8%], HLA-B51 [0.8%] and HLA-Cw7 [1.3%]). In conclusion, ET after kidney transplantation under tacrolimus/mycophenolate/prednisone-based immunosuppression was not associated with rejection, de novo HLA-DSA formation, and broadened HLA sensitisation arguing against the clinical need for HLA-matched/selected ET in this setting.
Identifiers
- OPENALEX
- https://openalex.org/W7225312783
- DOI
- 10.1111/tan.71068
- PMID
- https://pubmed.ncbi.nlm.nih.gov/42984328
- PMCID
- https://www.ncbi.nlm.nih.gov/pmc/articles/13735889
Documentary context
- Documentary family
- article
- Source-reported types
- article
- Publishers
- Wiley
Entity mentions are not evidence of legal recognition. Jurisdiction studied is separate from author affiliation country.
Sources
OpenAlex · Record 1
Cite this reference
Stella L. Gerber; Matthias Diebold; Gideon Hönger; Caroline Wehmeier; Thomas E. Wolff; Edin Mujagić; Corinne C. Widmer; Andreas S. Buser; Stefan Schaub. Impact of Blood Transfusions After Kidney Transplantation on Clinical Outcomes and Broadness of Sensitisation. 2026. https://doi.org/10.1111/tan.71068
JSON · CSL-JSON · BibTeX · RIS · CSV · JSON-LD ·
APA, Chicago, ISO 690: bibliographic formats using available fields. OSCOLA / Bluebook: structured data only; full legal citation compliance is not claimed without verification of required elements.
- APA
- Stella L. Gerber; Matthias Diebold; Gideon Hönger; Caroline Wehmeier; Thomas E. Wolff; Edin Mujagić; Corinne C. Widmer; Andreas S. Buser; Stefan Schaub. (2026). Impact of Blood Transfusions After Kidney Transplantation on Clinical Outcomes and Broadness of Sensitisation. https://doi.org/10.1111/tan.71068
- Chicago
- Stella L. Gerber; Matthias Diebold; Gideon Hönger; Caroline Wehmeier; Thomas E. Wolff; Edin Mujagić; Corinne C. Widmer; Andreas S. Buser; Stefan Schaub. Impact of Blood Transfusions After Kidney Transplantation on Clinical Outcomes and Broadness of Sensitisation. 2026. https://doi.org/10.1111/tan.71068
- ISO 690
- Stella L. Gerber; Matthias Diebold; Gideon Hönger; Caroline Wehmeier; Thomas E. Wolff; Edin Mujagić; Corinne C. Widmer; Andreas S. Buser; Stefan Schaub. Impact of Blood Transfusions After Kidney Transplantation on Clinical Outcomes and Broadness of Sensitisation. 2026. https://doi.org/10.1111/tan.71068
Warning: Undefined array key "last_link_verified" in /home/clients/e27d81e12f04d2bfd747aa264540ac56/sites/_UDTR_APP/legal_library_reference.php on line 31
UDTR Global Rights of Nature Legal Library. Impact of Blood Transfusions After Kidney Transplantation on Clinical Outcomes and Broadness of Sensitisation. Documentary record: https://www.declarationuniverselledesdroitsdelarbre.org/global-rights-of-nature-radar/reference/r-409df374cedd1404e7c76c654c2a81ce/ · Last HTTP verification: not performed
Research dossiers and documentary relations
Source roles
Bibliographic / original publication source · https://doi.org/10.1111/tan.71068
An authority link alone does not verify a legal claim. Abstracts and full texts remain subject to their source terms.
Documentary status
Relevance pending
Library
This identity is not yet included in the Legal Library.